CD24 and cancer: These nanoreactors exhibited the ability to reactivate T cells and infiltrating macrophages by blocking the CD24-Siglec-10 and PD-L1-PD1 signaling pathways, leading to the secretion of IFN-γ and enhanced cancer cell killing.